© 2012 Future Path Medical Holding Company, LLC All Rights Reserved
Future Path Medical has developed UroSense™, a medical device system that automates urine output and core body temperature (CBT) data gathering and charting for catheterized patients.
These two vital signs can now be measured automatically, as opposed to current manual, inaccurate and time intensive methods .
By monitoring these vital signs, one can trigger care protocols which can facilitate early treatment and diagnosis of heart failure, kidney injury, infectious disease, large prostate tumors, diabetes, sepsis and burn patient status in addition to Core Body Temperature (CBT) indicators of infection and hypothermia .
UroSense has been cleared by the FDA as a Class II Device.